drugset / Trial / NCT04368910
Safety and Efficacy of Pyronaridine Artesunate Vs Chloroquine in Children and Adult Patients With Acute Vivax Malaria
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The primary objective of this clinical study is to compare the efficacy and safety of the fixed combination of pyronaridine artesunate (180:60 mg) with that of standard chloroquine therapy in children and adults with acute, uncomplicated Plasmodium vivax (P. vivax) malaria
Timeline
- Start
- 2007-09-06
- Primary completion
- 2010-10-16
- Completion
- 2010-11-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Artesunate | Small molecule | 60 mg | Oral |
| Comparator | Chloroquine | Small molecule | 155 mg | Oral |
| Subject | Pyronaridine | Unknown | 180 mg | Oral |